These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15034591)

  • 1. Too little, too late: when is the right time for new leadership in biotech?
    Branthwaite P; Williams SJ
    Nat Biotechnol; 2004 Apr; 22(4):487-8. PubMed ID: 15034591
    [No Abstract]   [Full Text] [Related]  

  • 2. Reinventing the biotech manager.
    Li J; Halal WE
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE61-3. PubMed ID: 12089592
    [No Abstract]   [Full Text] [Related]  

  • 3. Leadership management needs in evolving biotech companies.
    Föller A
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE64-6. PubMed ID: 12089593
    [No Abstract]   [Full Text] [Related]  

  • 4. Making it in the biotech business.
    Gewin V
    Nature; 2005 May; 435(7038):124-5. PubMed ID: 15875029
    [No Abstract]   [Full Text] [Related]  

  • 5. Converting biotech scientists into managers.
    Jensen DG; Dougherty E
    Nat Biotechnol; 2004 Mar; 22(3):357-8. PubMed ID: 15017990
    [No Abstract]   [Full Text] [Related]  

  • 6. Paring down the company: the effect of consolidation in the European biotech sector.
    Bassett P
    Nat Biotechnol; 2003 Jul; 21(7):829-30. PubMed ID: 12833105
    [No Abstract]   [Full Text] [Related]  

  • 7. Partnering challenges for startups.
    French JM
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE40-2. PubMed ID: 12089586
    [No Abstract]   [Full Text] [Related]  

  • 8. Syndication--value in numbers.
    Sanborn KT
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE54-6. PubMed ID: 12089590
    [No Abstract]   [Full Text] [Related]  

  • 9. Timing and the transitory nature of biotech startups.
    Bottles K
    Physician Exec; 2001; 27(4):55-7. PubMed ID: 11481895
    [No Abstract]   [Full Text] [Related]  

  • 10. Taiwan: Biotech vision.
    Cyranoski D
    Nat Biotechnol; 2003 Apr; 21(4):463-4. PubMed ID: 12665831
    [No Abstract]   [Full Text] [Related]  

  • 11. The development of China's medical biotech industry needs to be driven by innovation.
    Yu Z; Dai Y
    Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-licensing as a business model.
    Schafer DP
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE36-9. PubMed ID: 12089585
    [No Abstract]   [Full Text] [Related]  

  • 13. Proactive accounting: a key factor in the success of biotechnology startups.
    Jester C
    Nat Biotechnol; 2004 Jan; 22(1):127-9. PubMed ID: 14725301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stranger in a strange land?
    Dahiyat B
    Nat Biotechnol; 2012 Nov; 30(11):1030-2. PubMed ID: 23138291
    [No Abstract]   [Full Text] [Related]  

  • 15. The challenge of leadership in technology and education.
    Chambers JW
    J Am Coll Dent; 2004; 71(4):22-5. PubMed ID: 15948489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotech venture capital--it's not too late to be early.
    Klausner A
    Nat Biotechnol; 2005 Apr; 23(4):417-8. PubMed ID: 15815662
    [No Abstract]   [Full Text] [Related]  

  • 17. Perspective: Biotech funding trends: Insights from entrepreneurs and investors.
    Gruber AC
    Biotechnol J; 2009 Aug; 4(8):1102-5. PubMed ID: 19685460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The startup balancing act: hiring the right talent.
    Moroney S
    Nat Biotechnol; 1998 May; 16 Suppl():39-40. PubMed ID: 9591265
    [No Abstract]   [Full Text] [Related]  

  • 19. Good neighbours.
    Niiler E
    Nature; 2003 Dec; 426(6967):690-4. PubMed ID: 14668872
    [No Abstract]   [Full Text] [Related]  

  • 20. A work in progress.
    Polvino B
    Nat Biotechnol; 2012 May; 30(5):388-9. PubMed ID: 22565957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.